Home  »  Business   »  Buy or Sell Revolution Medicines Inc. (RVMD) Stock...

Buy or Sell Revolution Medicines Inc. (RVMD) Stock Now | Don’t Try to Be a Top Gun

Revolution Medicines Inc. (NASDAQ:RVMD) went up by 4.69% from its latest closing price compared to the recent 1-year high of $29.29. The company’s stock price has collected 6.89% of gains in the last five trading sessions.

Is It Worth Investing in Revolution Medicines Inc. (NASDAQ :RVMD) Right Now?

Opinions of the stock are interesting as 6 analysts out of 9 who provided ratings for Revolution Medicines Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $29.13, which is $7.26 above the current price. RVMD currently public float of 87.08M and currently shorts hold a 11.35% ratio of that float. Today, the average trading volume of RVMD was 818.05K shares.

RVMD’s Market Performance

RVMD stocks went up by 6.89% for the week, with a monthly jump of 14.57% and a quarterly performance of -4.12%, while its annual performance rate touched -23.83%. The volatility ratio for the week stands at 6.59% while the volatility levels for the past 30 days are set at 6.62% for Revolution Medicines Inc. The simple moving average for the period of the last 20 days is 6.45% for RVMD stocks with a simple moving average of 6.15% for the last 200 days.

Analysts’ Opinion of RVMD

Many brokerage firms have already submitted their reports for RVMD stocks, with Oppenheimer repeating the rating for RVMD by listing it as a “Outperform.” The predicted price for RVMD in the upcoming period, according to Oppenheimer is $30 based on the research report published on October 21st of the current year 2022.

BofA Securities, on the other hand, stated in their research note that they expect to see RVMD reach a price target of $24. The rating they have provided for RVMD stocks is “Neutral” according to the report published on May 20th, 2022.

Stifel gave a rating of “Buy” to RVMD, setting the target price at $26 in the report published on March 01st of the current year.

RVMD Trading at 11.37% from the 50-Day Moving Average

After a stumble in the market that brought RVMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.37% of loss for the given period.

Volatility was left at 6.62%, however, over the last 30 days, the volatility rate increased by 6.59%, as shares surge +10.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.18% upper at present.

During the last 5 trading sessions, RVMD rose by +6.89%, which changed the moving average for the period of 200-days by +2.25% in comparison to the 20-day moving average, which settled at $20.64. In addition, Revolution Medicines Inc. saw -13.15% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at RVMD starting from Horn Margaret A, who sale 17,767 shares at the price of $20.15 back on Nov 07. After this action, Horn Margaret A now owns 0 shares of Revolution Medicines Inc., valued at $358,069 using the latest closing price.

Horn Margaret A, the Chief Operating Officer of Revolution Medicines Inc., sale 17,767 shares at $20.41 during a trade that took place back on Oct 31, which means that Horn Margaret A is holding 17,767 shares at $362,541 based on the most recent closing price.

Stock Fundamentals for RVMD

Current profitability levels for the company are sitting at:

  • -639.70 for the present operating margin
  • +75.05 for the gross margin

The net margin for Revolution Medicines Inc. stands at -636.58. Equity return is now at value -42.00, with -34.00 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 9.77.

Is Twilio Inc. (TWLO) a Keeper?

Twilio Inc. (NYSE:TWLO) went down by -5.24% from its latest closing price compared to the recent 1-year high of $289.00. The company’s stock price has